Approval · Notice of Compliance 30035 · 2023
RUPALL: Notice of Compliance 30035
Issued February 2, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30035
- Date
- February 2, 2023
- Company
- Medexus Inc
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Change in Product Ownership
Products in this notice
Medicinal ingredients
- RUPATADINE FUMARATE 10 MG per TAB
- RUPATADINE FUMARATE 1 MG per ML